Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NICHOLAS JAMES SHORT

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1396039178
CMS profile
915331
Location
HOUSTON, TX

General Payments · PY2018–2024

$153,510.44

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$47,870.50

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Adaptive Biotechnologies Corporation $26,077.60 17
Amgen Inc. $15,455.00 4
GENZYME CORPORATION $5,982.00 1
Astellas Pharma US Inc $146.79 1
Astellas Pharma Global Development $116.28 1
Celgene Corporation $66.22 3
ABBVIE INC. $26.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,081.90 7
PY2019 $11,178.00 2
PY2020 $3,500.00 1
PY2021 $11,687.04 5
PY2022 $24,221.54 15
PY2023 $47,971.46 28
PY2024 $47,870.50 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.61 04/25/2024 Food and Beverage Undisputed 01/23/2026 1106091654 CMS
Adaptive Biotechnologies Corporation $400.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1150259770 CMS
Adaptive Biotechnologies Corporation $4,400.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1150259774 CMS
Adaptive Biotechnologies Corporation $800.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1150259782 CMS
Adaptive Biotechnologies Corporation $6,800.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1150259778 CMS
Adaptive Biotechnologies Corporation $341.70 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1150264143 CMS
Adaptive Biotechnologies Corporation $293.26 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1150264145 CMS
Adaptive Biotechnologies Corporation $1,400.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 1150259776 CMS
Adaptive Biotechnologies Corporation $5,200.00 05/02/2024 Consulting Fee Undisputed 01/23/2026 1150259772 CMS
Adaptive Biotechnologies Corporation $139.36 05/02/2024 Travel and Lodging Undisputed 01/23/2026 1150264147 CMS
Adaptive Biotechnologies Corporation $131.18 07/01/2024 Food and Beverage Undisputed 01/23/2026 1150263705 CMS
Adaptive Biotechnologies Corporation $100.60 07/10/2024 Food and Beverage Undisputed 01/23/2026 1150263709 CMS
Adaptive Biotechnologies Corporation $14.58 07/12/2024 Food and Beverage Undisputed 01/23/2026 1150263707 CMS
Adaptive Biotechnologies Corporation $4,800.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1150259780 CMS
Adaptive Biotechnologies Corporation $273.28 08/01/2024 Travel and Lodging Undisputed 01/23/2026 1150264149 CMS
Adaptive Biotechnologies Corporation $496.98 08/01/2024 Travel and Lodging Undisputed 01/23/2026 1150264151 CMS
Adaptive Biotechnologies Corporation $376.95 08/01/2024 Travel and Lodging Undisputed 01/23/2026 1150264153 CMS
Adaptive Biotechnologies Corporation $109.71 11/19/2024 Food and Beverage Undisputed 01/23/2026 1150263711 CMS
Amgen Inc. $4,439.50 05/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1116121779 CMS
Amgen Inc. $5,585.50 05/02/2024 Travel and Lodging Undisputed 01/23/2026 1116121785 CMS
Amgen Inc. $3,430.00 09/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1116121765 CMS
Amgen Inc. $2,000.00 12/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1116121771 CMS
Astellas Pharma Global Development $116.28 06/01/2024 Food and Beverage Undisputed 01/23/2026 1132965965 CMS
Astellas Pharma US Inc $146.79 09/14/2024 Food and Beverage Undisputed 01/23/2026 1139392068 CMS
Celgene Corporation $20.80 01/23/2024 Food and Beverage Undisputed 01/23/2026 1101191857 CMS
Celgene Corporation $16.17 01/30/2024 Food and Beverage Undisputed 01/23/2026 1101191859 CMS
Celgene Corporation $29.25 02/20/2024 Food and Beverage Undisputed 01/23/2026 1101191861 CMS
GENZYME CORPORATION $5,982.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1139951359 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.